CoDa Therapeutics Receives $19,200,000 Series B Funding Round

  • Feed Type
  • Date
    4/18/2011
  • Company Name
    CoDa Therapeutics
  • Mailing Address
    10505 Sorrento Valley Road San Diego, CA 92121
  • Company Description
    CoDa Therapeutics, Inc. is a San Diego-based pharmaceutical company focused on the development and commercialization of wound care therapeutics based on gap junction modulation.
  • Website
    http://www.codatherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $19,200,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The financing will allow us to take essential steps for the development of CoDa; in particular, we will now conduct a large Phase 2 multicenter venous leg ulcer trial in the United States, New Zealand and Australia with Nexagon®, our lead product for chronic wound patients. In addition, we will continue the preclinical development of our product portfolio in our research laboratories.
  • M&A Terms
  • Venture Investor
    Domain Associates
  • Venture Investor
    GBS Venture Partners
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.